跳至主要内容
临床试验/TCTR20210811002
TCTR20210811002招募中4 期

Antineuralgic Effect of Lacosamide (Vimpat) in Trigeminal Neuralgia Patients

eurosciences Research and Development Group, Khonkaen University0 个研究点目标入组 48 人开始时间: 2021年8月11日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 80 Years(—)
性别
All

入选标准

  • 2. Diagnosed as trigeminal neuralgia according to International Classification of Headache Disorder 3rd edition (ICHD-3)
  • 3. Numeric rating scale of pain higher than 4
  • 4. Never received any treatment or have not taken any drugs in last 4 weeks
  • 5. Physical condition is categorized as American Society of Anesthesiologist (ASA classification) 1 or 2
  • 6. Can communicate in Thai

排除标准

  • 1. History of microvascular decompression surgery without recurred symptom
  • 2. Impaired physical condition or psychological problems
  • 3. Pregnancy and lactation
  • 4. History of suicide commitment
  • 5. Impaired liver or kidney functions
  • 6. History of experimental drug allergy
  • 7. Unwilling to join the sudy
  • 8. Could not come to follow up regularly

研究者

发起方
eurosciences Research and Development Group, Khonkaen University

相似试验